efficacy and safety of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate response to intial 4 week solifenacin monotherapy

ESEN A. A., drake m., athanasiou s., herholdt c., saleem t., huang m., ...More

Annual Meeting of the American-Urological-Association (AUA), 15 - 19 May 2015

  • Publication Type: Conference Paper / Full Text
  • Dokuz Eylül University Affiliated: Yes